The research team, led by Agostino Stavolo of the University of Naples Federico II together with Giulia Cavrini and Viviana Egidi, drew on the Survey of Health, Ageing and Retirement in Europe (SHARE), a longitudinal panel that has tracked ageing populations across the continent for two decades. They analyzed data from Waves 6 through 8, spanning 2015 to 2019/20, covering 28,187 community-dwelling adults aged 50 and older. The timing was deliberate: Wave 8 was the last data collection before the COVID-19 pandemic, which the authors note disrupted sampling, biased self-reported health measures and compromised the comparability of physical frailty measurements across countries. By ending before the pandemic, the study offers a clean window onto frailty dynamics under normal conditions.

Frailty itself was measured using the SHARE-adapted version of the Frailty Phenotype, first proposed by Linda Fried and colleagues in 2001. The instrument scores five physical criteria: unintentional weight loss, self-reported exhaustion, weak grip strength, slow walking speed, and low physical activity. People meeting none of the criteria are classified as non-frail; one or two criteria indicate pre-frailty; three or more define established frailty. What makes this study methodologically distinctive is how it modeled movement between those states. Rather than comparing snapshots at two time points, the team fitted a continuous-time multi-state Markov model, treating death as an absorbing state. This statistical machinery estimates the instantaneous risk of transitioning between any two health states at any moment between survey waves, allowing deterioration, recovery and mortality to be quantified simultaneously within a single framework.

The raw transition numbers already tell a compelling story. Among people who were non-frail at baseline, 61 percent remained stable, 34 percent slipped into pre-frailty, 2 percent progressed directly to frailty, and 3 percent died. Pre-frail individuals — the largest and most heterogeneous group — proved surprisingly dynamic: 57 percent stayed the same, but 28 percent recovered fully to a non-frail state, 7 percent became frail, and 8 percent died. Most striking of all, among those classified as frail at the start, 35 percent improved back to pre-frailty within the follow-up period, although only 2 percent returned all the way to non-frail status. The frail group also carried the heaviest mortality burden: 36 percent died during the observation window, compared with just 3 percent of the non-frail. The pattern confirms that frailty typically arrives gradually, through an intermediate pre-frail stage, and that the pre-frail state is where the most clinically meaningful recovery happens.

When the researchers examined which factors predicted those transitions, age emerged as the most powerful and consistent driver. Being 75 or older cut the rate of recovery from frailty by roughly 37 percent (hazard ratio 0.63) and halved the chance of recovering from pre-frailty (HR 0.49). On the worsening side, the age gradient was even steeper: adults 75 and older faced a 64 percent higher risk of sliding from non-frail to pre-frail, and a more than fourfold risk (HR 4.06) of progressing from pre-frailty to full frailty compared with people aged 50 to 74. Age also dominated mortality risk at every frailty level, multiplying the death rate more than fivefold among non-frail individuals and nearly doubling it even among the already frail. The authors point to a possible tipping point near age 75, consistent with dynamical modeling suggesting that physiological resilience declines sharply once accumulated health deficits cross a critical threshold.

But the headline finding is the independent role of psychosocial and socioeconomic factors — variables that earlier studies had tended to examine separately. Perceived loneliness, measured as the subjective feeling of being lonely rather than objective social isolation, cut the rate of recovery from pre-frailty by 35 percent (HR 0.65) and raised the risk of progressing from pre-frailty to frailty by 53 percent (HR 1.53). It also elevated mortality among pre-frail individuals (HR 1.29). The biological plausibility is well established: loneliness is associated with chronic low-grade inflammation, dysregulation of the hypothalamic–pituitary–adrenal stress axis, impaired immune function, reduced physical activity, poorer sleep and higher depression risk. What this study adds is evidence of precisely where loneliness bites hardest — at the pre-frail stage, the very window when intervention is most effective.

Financial difficulties told a similar story through a different mechanism. People who reported difficulty making ends meet showed an 18 percent higher risk of deteriorating from non-frail to pre-frail, an 83 percent lower recovery rate from pre-frailty after adjustment, and elevated mortality risk at every frailty level — including a 58 percent higher death rate even among those who were not frail at baseline. The pathways are structural: economic hardship limits access to healthcare and preventive services, constrains nutrition, makes assistive devices and home adaptations unaffordable, and imposes a chronic psychological burden of insecurity that compounds over the life course. Notably, these effects were detectable well before clinical frailty became manifest, suggesting that socioeconomic disadvantage quietly shapes vulnerability trajectories years in advance.

Chronic disease burden rounded out the individual-level picture. Having at least one chronic condition raised the risk of initial deterioration by 22 percent and more than doubled the rate of progression from pre-frailty to frailty (HR 2.53). It also roughly doubled mortality risk among pre-frail individuals and increased it 61 percent among the frail. The relationship between multimorbidity and frailty is mutually reinforcing: chronic diseases accelerate deficit accumulation through inflammation, sarcopenia and pharmacological burden, while frailty in turn erodes the capacity to manage those diseases. Women, meanwhile, presented a familiar paradox: they showed modestly lower recovery rates from pre-frailty but a markedly lower mortality risk across all states — a hazard ratio of 0.41 among the pre-frail — consistent with the well-documented female survival advantage that persists even in the presence of frailty.

Where people lived mattered too, and not simply because of who lived there. Older adults in Northern-Continental Europe — including the Nordic and Continental welfare states — enjoyed significantly better outcomes than their Mediterranean counterparts, with a 49 percent higher recovery rate from frailty, a 60 percent higher recovery rate from pre-frailty, and roughly half the mortality risk among non-frail individuals. Eastern European residents in the pre-frail group faced a 27 percent higher mortality risk. Crucially, these regional gradients persisted after the model accounted for individual age, gender, health, loneliness and financial status, implying that structural context — welfare generosity, healthcare accessibility, rehabilitation services and social protection systems — exerts an influence that cannot be reduced to the characteristics of the people themselves. The authors identified the three macro-regions using an exploratory multiple correspondence analysis of country-level Eurostat indicators, including unmet healthcare needs, health expenditure, and healthy life expectancy at 65.

The practical implications are hard to ignore. The study positions the pre-frail state as the single most actionable window for prevention: once full frailty is established, complete recovery becomes rare, but nearly three in ten pre-frail individuals can bounce back. Interventions targeting loneliness among pre-frail adults — through social prescribing, community programs or structured social contact — may delay or prevent progression in ways that clinical management of chronic disease alone cannot. Likewise, policies that relieve financial hardship in old age are, in effect, health policies. The authors also acknowledge limitations: frailty was observed only at two waves with valid measurement, so the timing of transitions within the interval cannot be recovered; covariates were fixed at baseline; mortality ascertainment varies across countries; and chronic conditions were reduced to a simple binary measure. Even so, the central message stands. Frailty is not destiny written into the ageing body — it is a dynamic, partly reversible process whose trajectory is shaped by loneliness, money, disease and the societies people age in, and the earlier those forces are addressed, the greater the chance of bending the curve back toward health.

Subject of Research: Determinants of frailty state transitions and reversibility among older adults in Europe, focusing on psychosocial, socioeconomic and macro-regional factors using SHARE longitudinal data

Article Title: Determinants of Frailty Dynamics in Europe: The Role of Psychosocial Factors

Article References: Stavolo, A., Cavrini, G., & Egidi, V. (2026). Determinants of Frailty Dynamics in Europe: The Role of Psychosocial Factors. Social Indicators Research, 184(3), Article 48. https://doi.org/10.1007/s11205-026-03940-7

Image Credits: AI Generated

DOI: 10.1007/s11205-026-03940-7

Keywords: frailty, ageing, loneliness, psychosocial factors, financial hardship, chronic disease, SHARE survey, multi-state Markov model, pre-frailty, mortality, European welfare states, population ageing